Inventor · disambiguated record
Irina Nikolaevna Kadiyala
Also filed as: KADIYALA IRINA · KADIYALA IRINA N · KADIYALA IRINA NIKOLAEVNA
17 granted patents·18 pending applications·419 citations·filing 1998–2024
95Inventor score
Files withVERTEX PHARMA20BIOMED VALLEY DISCOVERIES INC6ALARGOVA ROSSITZA GUEORGUIEVA2GUILFORD PHARM INC2CONNELLY PATRICK R1
Top patents by PatentIndex Score
35 records- 0197US10058546B2Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereofVERTEX PHARMA·Filed 2016·Granted Aug 28, 2018·28 cites·14 claims
- 0297US9241934B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2014·Granted Jan 26, 2016·58 cites·37 claims
- 0396US10076513B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2016·Granted Sep 18, 2018·27 cites·49 claims
- 0495US11052075B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2019·Granted Jul 6, 2021·13 cites·22 claims
- 0595US9012496B2Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereofVertex Pharmaceuticals Incorported·Filed 2013·Granted Apr 21, 2015·63 cites·19 claims
- 0695US8552034B2Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERWIJS MARINUS JACOBUS·Filed 2011·Granted Oct 8, 2013·98 cites·55 claims
- 0793US9676746B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jun 13, 2017·6 cites·82 claims
- 0891US8563593B2Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideALARGOVA ROSSITZA GUEORGUIEVA·Filed 2011·Granted Oct 22, 2013·71 cites·34 claims
- 0988US10039761B2Co-crystals and pharmaceutical compositions comprising the sameVERTEX PHARMA·Filed 2016·Granted Aug 7, 2018·4 cites·21 claims
- 1087US10716789B2Co-crystals and pharmaceutical compositions comprising the sameVERTEX PHARMA·Filed 2018·Granted Jul 21, 2020·3 cites·22 claims
- 1186US2025084059A1CRYSTALLINE FORMS OF C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 1282US10183927B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Jan 22, 2019·2 cites·26 claims
- 1380US12187698B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2022·Granted Jan 7, 2025·0 cites·10 claims
- 1477US2022031679A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1573US10738027B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2018·Granted Aug 11, 2020·0 cites·10 claims
- 1673US6800672B2Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the sameGUILFORD PHARM INC·Filed 2001·Granted Oct 5, 2004·9 cites·65 claims
- 1772US11390600B2Crystalline forms of C21H22Cl2N4O2BIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Jul 19, 2022·0 cites·10 claims
- 1872US6403675B1Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the sameGUILFORD PHARM INC·Filed 1998·Granted Jun 11, 2002·37 cites·33 claims
- 1966US2019070155A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2063US2014023706A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2161US2013095181A1Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2258US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2357US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2457US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2556US2015182517A1Pharmaceutical Compositions of (R)-1-(2,2-Difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and Administration ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2655US8759353B2Co-crystals and pharmaceutical compositions comprising the sameCONNELLY PATRICK R·Filed 2008·Granted Jun 24, 2014·0 cites·32 claims
- 2752US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2851US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2951US2008070972A1Controlled release formulationsKADIYALA IRINA N·Filed 2007·Application pending·0 cites
- 3049US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3148US2014094499A1Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 3243US2014243273A1Methods for treating inflammatory diseases and pharmaceutical combinations useful thereforVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3342US2011021598A1Controlled release formulationsVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 3440US2007225339A1Compositions and methods for treating rheumatoid arthritisMOHANLAL RAMON·Filed 2007·Application pending·0 cites
- 3536US2012046330A1Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereofALARGOVA ROSSITZA GUEORGUIEVA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Irina Nikolaevna Kadiyala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →